Johnson M C, Meyer A A, deSerres S, Herzog S, Peterson H D
Department of Surgery, University of North Carolina School of Medicine, Chapel Hill 27599.
J Burn Care Rehabil. 1990 Nov-Dec;11(6):504-9.
Cultured human keratinocytes are used for skin grafts, but their success is limited by late graft loss. Development of antibody to fetal bovine serum (FBS) protein used in culture media for in vitro keratinocyte growth has been identified. The persistence of FBS antigen in skin grafts is important in the induction of the immune response and the susceptibility of the keratinocytes to immune-mediated injury. The magnitude and longevity of FBS protein persistence on human keratinocytes was studied. Secondary passage human keratinocytes were grown in media supplemented with 5% FBS. The media was changed to one supplemented with pooled human AB serum, and the amount of FBS protein incorporated in the tissue was measured over the following 8 days by an ELISA reaction directed against FBS antigen. Incorporated FBS antigen decreased for the first 3 days to 31% of maximum. There was no further significant decrease for 5 days. Keratinocytes grown in alternative serum supplements (NuSerum [Collaborative Research Inc., Bedford, Mass.] and Serum Plus [Hazelton Research Products Inc., Lenexa, Kan.]), which contain reduced amounts of FBS, offered no significant reduction in FBS protein incorporation. This duration of antigen persistence would make human keratinocytes susceptible to cell destruction by immune response to FBS and may contribute to delayed loss of human keratinocyte grafts.
培养的人角质形成细胞用于皮肤移植,但它们的成功率受到移植后期丢失的限制。已发现针对用于体外角质形成细胞生长的培养基中使用的胎牛血清(FBS)蛋白产生抗体。FBS抗原在皮肤移植中的持续存在对于免疫反应的诱导以及角质形成细胞对免疫介导损伤的易感性很重要。研究了FBS蛋白在人角质形成细胞上的持续时间和强度。将第二代人角质形成细胞在补充有5%FBS的培养基中培养。将培养基更换为补充有混合人AB血清的培养基,并在接下来的8天内通过针对FBS抗原的ELISA反应测量组织中掺入的FBS蛋白量。掺入的FBS抗原在最初3天降至最大值的31%。在接下来的5天内没有进一步显著下降。在含有减少量FBS的替代血清补充剂(NuSerum [协作研究公司,马萨诸塞州贝德福德]和血清加[黑泽尔顿研究产品公司,堪萨斯州莱尼克斯])中生长的角质形成细胞,FBS蛋白掺入量没有显著减少。这种抗原持续时间会使人角质形成细胞容易受到针对FBS的免疫反应导致的细胞破坏,并可能导致人角质形成细胞移植的延迟丢失。